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Abstract
Background:  The results of a cross-sectional study aimed to evaluate whether genetic
polymorphisms (biomarkers of susceptibility) for CYP1A1, EPHX and GSTM1 genes that affect
polycyclic aromatic hydrocarbons (PAH) activation and detoxification might influence the extent of
primary DNA damage (biomarker of biologically effective dose) in PAH exposed workers are
presented. PAH-exposure of the study populations was assessed by determining the concentration
of 1-hydroxypyrene (1OHP) in urine samples (biomarker of exposure dose).
Methods:  The exposed group consisted of workers (n = 109) at a graphite electrode
manufacturing plant, occupationally exposed to PAH. Urinary 1OHP was measured by HPLC.
Primary DNA damage was evaluated by the alkaline comet assay in peripheral blood leukocytes.
Genetic polymorphisms for CYP1A1, EPHX and GSTM1 were determined by PCR or PCR/RFLP
analysis.
Results:  1OHP and primary DNA damage were significantly higher in electrode workers
compared to reference subjects. Moreover, categorization of subjects as normal or outlier
highlighted an increased genotoxic risk OR = 2.59 (CI95% 1.32–5.05) associated to exposure to
PAH. Polymorphisms in EPHX exons 3 and 4 was associated to higher urinary concentrations of
1OHP, whereas none of the genotypes analyzed (CYP1A1, EPHX, and GSTM1) had any significant
influence on primary DNA damage as evaluated by the comet assay.
Conclusion: The outcomes of the present study show that molecular epidemiology approaches
(i.e. cross-sectional studies of genotoxicity biomarkers) can play a role in identifying common
genetic risk factors, also attempting to associate the effects with measured exposure data.
Moreover, categorization of subjects as normal or outlier allowed the evaluation of the association
between occupational exposure to PAH and DNA damage highlighting an increased genotoxic risk.
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Background
Graphite electrodes are used in the metal industry, mainly
in electric arc furnace steel production, to refine steel in
ladle furnaces, and in other smelting processes [1]. The
production process of graphite electrodes involves the use
of coal tar, coal tar pitch and petroleum coke with workers
possibly exposed to polycyclic aromatic hydrocarbons
(PAH) by inhalation (of PAH both volatile and bound to
respirable particulate matter) and dermal contact [2].
Occupational exposure of workers to PAH-containing
coal tar pitch volatiles, pitch and coke occurs during the
manufacturing process particularly during the heating of
raw materials [3-6]. Occupational exposure to PAH was
associated with increased risk of developing lung, skin,
bladder and prostate cancer among graphite electrode
manufacturing workers [2,7-10].
Several hundred PAH have been characterized for their
chemistry and many individual PAH (e.g.  benzo
[a]pyrene, benzo [a]anthracene, dibenzo [a, h]anthra-
cene) are regarded as probably or possibly carcinogenic to
humans by the International Agency for Research on Can-
cer (group 2A or 2B) [11]. The carcinogenic activity of
PAH is related to the DNA damaging activity of some of
their metabolites which can covalently bind to nucle-
ophilic residues of DNA bases. The PAH are activated to
the corresponding electrophilic diolepoxides (ultimate
carcinogens) via cytochrome P450 (CYP) enzyme system
[12]. The inactivation of diolepoxide metabolites occurs
mainly through conjugation with reduced glutathione
(GSH) by glutathione S-transferase (GST) enzymes [13].
Many genes encoding carcinogens metabolising enzymes
have been found to be polymorphic in humans, with rel-
evance to the individual response to carcinogens, proba-
bly acting as modifiers of exposure biomarkers
(susceptibility markers) [14-16].
A critical polymorphic gene which contributes to the bio-
activation of many PAH is the CYP1A1 encoding the cyto-
chrome P4501A1 enzyme (CYP1A1), an inducible
enzyme with aryl hydrocarbon hydroxylase activity.
Among several polymorphisms identified in the CYP1A1
gene, two closely linked mutations have been extensively
studied in relation to cancer risk. The CYP1A1 Ile/Val (m2)
mutation in the heme-binding region doubles the micro-
somal enzyme activity and it is in linkage disequilibrium
in Caucasians with the CYP1A1 MspI (m1) mutation, that
has also been associated experimentally with increased
catalytic activity [17]. Positive associations between the
presence of these variant alleles and increased PAH-DNA
adducts have been reported [18-20].
A further critical enzyme in PAH metabolism is micro-
somal epoxide hydrolase (mEH) which catalyses the
hydrolysis of epoxides into dihydrodiols, and as such
plays an important role in the detoxification of toxic,
highly reactive, intermediates formed by cytochrome
P450-mediated reactions [21]. Low mEH activity has been
associated with adverse drug responses or diseases states
[22]. Two polymorphic sites within the mEH gene (EPHX)
have been identified. A substitution at codon 113 (Tyr →
His) in exon 3 is associated with decreased mEH activity,
whereas a substitution at codon 139 (His → Arg) in exon
4 is associated with increased mEH activity. These muta-
tions affect mEH enzyme activity by altering protein sta-
bility without affecting the specific activity [23].
The GSTM1 gene encodes for the cytosolic enzyme glu-
tathione S-transferase µ1 (GSTM1) that detoxify activated
forms of chemical carcinogens such as polyaromatic
hydrocarbon epoxides. This gene is deleted in about 50%
of Caucasians, with a reported variation of from 38 to
65% [24]. The inherited absence of the GSTM1 gene (the
GSTM1 null genotype) is therefore theoretically associ-
ated at a higher risk to the toxic effects of chemicals and its
influence on various biomarkers of exposure has been
widely studied [18,25-27].
In the present paper we reported the results of a cross-sec-
tional study aimed to evaluate whether genetic polymor-
phisms (biomarkers of susceptibility) for CYP1A1, EPHX
and GSTM1 genes that affect PAH activation and detoxifi-
cation might influence the extent of primary DNA damage
(biomarker of biologically effective dose) in PAH exposed
workers (n = 109) and in unexposed controls (n = 82).
PAH-exposure of the study populations was assessed by
determining the concentration of 1-hydroxypyrene
(1OHP) in urine samples (biomarker of exposure dose).
The urinary concentration of 1OHP, a metabolite of the
non carcinogenic PAH pyrene, is a well validated marker
for PAH-exposure [28] giving an accurate assessment of
total PAH exposure from all exposure routes [29]. The
extent of primary DNA damage was evaluated with the
comet assay in peripheral blood leukocytes (PBL) [30].
The study subjects were genotyped for polymorphisms in
the CYP1A1 gene (mutations associated with increased
catalytic activity) encoding the cytochrome P4501A1
enzyme, in the EPHX  gene (mutations influencing the
mEH enzyme activity) encoding for the mEH enzyme,
and the GSTM1 gene (inherited absence) encoding for the
cytosolic glutathione S-transferase µ1 (GSTM1).
Methods
Study Population and Samples Collection
A total of 191 healthy men living in the same area of Cen-
tral Italy were enrolled in the study. The exposed group
was composed of 109 workers at a graphite electrode pro-
ducing plant, occupationally exposed to PAH. The elec-
trode plant produces large electrodes (length 2.5÷3 m,BMC Public Health 2007, 7:270 http://www.biomedcentral.com/1471-2458/7/270
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diameter up to 1 m) and small bricks (diameter less than
0.1 m) of electrode paste for steel industry [3]. As a control
group, 82 reference subjects (not occupationally exposed
to PAH) were recruited from the technical and mainte-
nance staff of the University of Perugia.
Workers and reference subjects were interviewed to obtain
personal data and information on current job, smoking
habit, alcohol consumption, diet, and current and past
health status (including information on medicine intake,
X-ray examinations, and viral infections). Following
informed consent was obtained from all individuals
enrolled in the study, workers and reference subjects pro-
vided a urine sample for 1OHP determination and a
peripheral venous blood sample (using heparinized vacu-
tainer tubes) for the comet assay and genotyping. Biolog-
ical samples were collected from workers at the end of the
shift after at least 4 consecutive days at work. The samples
were coded and immediately transferred to the laboratory
in refrigerated boxes.
The research protocol was approved by the Ethics Com-
mittee of the University of Perugia.
CYP1A1, EPHX, and GSTM1 Genotyping
Total DNA was extracted from peripheral blood cells
using standard techniques. All genotypes were deter-
mined after gene amplification using polymerase chain
reactions (PCR) [31]. The T → C mutation (m1) in the 3'-
flanking region of CYP1A1 gene was detected by PCR fol-
lowed by restriction fragment length polymorphism
(RFLP) analysis using the restriction enzyme MspI [32].
The genotype w1/w1  (lacking the MspI site) forms an
uncleaved 340 bp band, while the genotype m1/m1
(homozygous for the allele carrying the mutation with the
MspI site) generates two bands of 200 and 140 bp. The
heterozygous genotype m1/w1 corresponds to three bands
of 340, 200, and 140 bp.
The CYP1A1 Ile/Val replacement (m2) was detected by
BsrDI-RFLP analysis [33]. The Ile/Val polymorphism
arises from a A → G base change resulting in the replace-
ment of isoleucine by valine at residue 462 in the heme
binding region of the enzyme. The Val allele variant shows
an almost two-fold higher catalytic enzyme activity than
Ile form.
Amplicons of exons 3 and 4 of EPHX gene (162, and 381
bp, respectively) were obtained by PCR, RFLP digestions
were then performed to determine the exon 3 (Tyr113His)
and exon 4 (His139Arg) genotypes, using the restriction
enzymes EcoRV and RsaI, respectively [31]. On the basis of
the polymorphisms at codon 113 (exon 3) and 139 (exon
4) of EPHX gene, the subjects were classified according to
expected mEH enzyme activity (low mEH, intermediate
mEH, or high mEH activity) [31].
GSTM1 genotyping for gene deletions was carried out by
detecting the presence or the absence of the intact gene
[34]. The absence of GSTM1 specific amplification prod-
ucts revealed the corresponding null genotype
(homozygous deletion of the GSTM1 gene, resulting in
deficiency of GSTM1 activity). The GSTM1 positive geno-
type, detected by the presence of GSTM1 specific band of
215 bp, contained wild-type homozygotes and heterozy-
gotes for the deletion (not differentiated in the analysis),
both expressing GSTM1 enzyme. Co-amplification of β-
globin gene was used as an internal control (presence of
amplifiable DNA in the sample).
Analysis of 1-Hydroxypyrene in Urine
Urinary concentrations of 1OHP were determined by
HPLC in enzymatically hydrolyzed urine samples [28].
Urine samples, adjusted to pH 5.0, were treated overnight
at 37°C with β-glucuronidase and aryl sulfatase and then
purified with solid phase extraction with Sep-Pack C18
cartridges primed with methanol. The cartridges were then
washed with high purity water and 1OHP was eluted with
methanol. The eluate was gently evaporated to dryness
under nitrogen and reconstituted in methanol. Of the
reconstituted eluate, 15 µl were injected into an HPLC and
1OHP, eluting at a retention time of 8 min, was detected
with excitation and emission wavelengths of 347 and 388
nm, respectively.
Analysis of Primary DNA Damage (Comet Assay) in 
Leukocytes
PBL were obtained from whole blood by lysis of erythro-
cytes [35]. Viability of cells after isolation was determined
by the fluorochrome-mediated (simultaneous staining
with fluorescein diacetate and propidium iodide) viability
test [36]. Isolated PBL were processed in the comet assay
following the standard alkaline protocol [37], with minor
modification [38,39].
The cells (2 × 105) were mixed with 0.7% low melting
temperature agarose (total volume 75 µl/slide) and sand-
wiched between a layer of 0.5% normal melting tempera-
ture agarose (75 µl) and a top layer of 0.7% low melting
temperature agarose (65 µl) onto conventional micro-
scope slides. Lysis of cellular and nuclear membranes of
the embedded cells was performed by immersing the
slides for 60 min, at 4°C in the dark, in ice-cold freshly
prepared lysis solution (10 mM Tris-HCl, 1% sodium N-
lauroylsarcosinate, 2.5 M NaCI, 100 mM Na2EDTA, 1%
triton X-100, and 10% DMSO; pH 10). The slides were
removed from the lysis solution and then placed on a hor-
izontal electrophoresis box. The unit was filled with
freshly made alkaline buffer (300 mM NaOH, 1 mMBMC Public Health 2007, 7:270 http://www.biomedcentral.com/1471-2458/7/270
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Na2EDTA; pH > 13) to a level of 0.25 cm over the slides.
To allow DNA unwinding and expression of alkali labile
damage, the embedded cells were exposed to alkali for 20
min, then the electrophoresis was performed in the same
buffer for 20 min by applying an electric field of 25 V (1
V/cm) and adjusting the current to 300 mA.
To control the assay conditions, particularly slides prepa-
ration procedure and electrophoresis efficiency, negative
and positive internal controls (Jürkat cells, human lym-
phoblastoid T-cells) were processed in parallel with whole
blood samples. Jürkat cells were untreated (negative con-
trol) or incubated for 1 h with 1 µg/ml 4-nitroquinoline-
N-oxide (positive control). Electrophoresis runs were con-
sidered valid only if the internal controls yielded the
expected results.
After electrophoresis, the slides were first washed gently
with 0.4 M Tris-HCl buffer (pH 7.5) to neutralize the
alkali, and the DNA was then stained by adding 100 µl of
ethidium bromide (2 µg/ml). The slides were kept in a
humidified sealed box to prevent drying of the gel and
analyzed within 48–72 hours.
Comets in each gel were analyzed (blind) at 500× magni-
fication using an epi-fluorescent microscope (excitation
filter, 515–560 nm; barrier filter, 590 nm) equipped with
a high sensitivity black and white CCD camera. For each
subject, the average tail length, tail intensity and tail
moment values were determined scoring 150 comets (50
comets/slide, from at least three replicate slides). Imaging
was performed using a specialized analysis system
("Comet Assay III", Perceptive Instruments).
Statistical Analysis of Data
The analyses were carried out using the SPSS 10.0 statisti-
cal software package (SPSS Inc., IL, USA). For each subject,
the averaged migration extents (i.e. tail length, tail inten-
sity, and tail moment) of the 150 cells analyzed were used
as a data point in data analysis. Cells were also classified
as either "undamaged" or "damaged" by considering
threshold levels indicating the cells with abnormal size
tail (AST) (i.e. the 95th percentile of the distribution of
the tail parameters among controls) [40]. Cells with tail
parameters values below the cut-off (18.87 µm, 16.73%,
and 1.90 for tail length, tail intensity, and tail moment,
respectively) were classified as "undamaged", and those
with higher values as "damaged". Based on these binary
outcomes, each subject was classified as "normal" or "out-
lier" by considering the upper bound of the expected
number of AST which was calculated for each subject from
the binomial distribution [41]. The latter outcome varia-
ble (i.e. each subject defined as normal or outlier) is again
binary, becoming the subject the statistical unit.
Group differences in concentration of 1OHP and extent of
primary DNA damage (individual averaged tail parame-
ters) were tested with the non-parametric Mann-Whitney
U-test (two-tailed). The Hardy-Weinberg equilibrium test
for genotype distribution was performed using a χ2 test
with 1 degree of freedom. The GSTM1  genotype was
coded as positive (wild-type homozygotes and heterozy-
gotes for the deletion) or null (homozygous deletion),
making direct calculation of Hardy-Weinberg equilibrium
impossible. The Pearson-χ2 test was used to determine sig-
nificant differences in the distribution of outliers subjects
and of allele frequencies of the considered genotypes
among the groups. Outlier subjects prevalence odds ratio
(OR) with 95% confidence intervals (95% CI) were calcu-
lated by means of cross tabulation. The level of statistical
significance was set at p < 0.05.
Results
Characteristics of the Study population
Demographic characteristics of the study population, also
grouped according to exposure status and smoking habits,
are reported in Table 1. With respect to age and smoking
habits, exposed and control groups were comparable. The
exposed workers and controls were stratified by geno-
types, CYP1A1 MspI (m1), CYP1A1 Ile/Val (m2), EPHX
and GSTM1 (Table 2). A similar frequency distribution
(Pearson-χ2 test) was observed in the groups for the con-
sidered genotypes. With regard to the CYP1A1 gene, 38
(20.2%) subjects resulted heterozygotes for the MspI
mutant allele, 27 (24.8%) exposed workers and 11
(13.8%) controls. The 5 (2.6%) MspI homozygotes indi-
viduals, 3 (2.8%) exposed workers and 2 (2.5%) controls,
were combined with heterozygous subjects for subse-
quent statistical analyses. In the group of 189 men exam-
ined, the mutant Val allele for CYP1A1 gene occurred in
17 (9.0%) individuals, 11 (10.1%) exposed workers and
6 (7.5%) controls. Only 1 (0.5%) person (control subject)
resulted to be a carrier of the homozygous Val/Val variant
of CYP1A1 and was combined with heterozygous individ-
uals for statistical analysis. About 50% of the studied sub-
jects (94 individuals) showed to have a low mEH deduced
activity (i.e. mEH activity deduction based on the results
of genotyping of EPHX polymorphisms in exons 3 and 4),
59 (54.1%) exposed workers and 35 (43.8%) controls.
The residual 95 subjects (50.3%), 50 (45.9%) exposed
workers and 45 (56.2%) controls, showed to have a
medium/high mEH deduced activity. The above reported
genotypes (i.e. CYP1A1 MspI (m1), CYP1A1 Ile/Val (m2),
EPHX), among exposed and control subjects were in
Hardy-Weinberg equilibrium (data not shown). In the
whole study population, the prevalence of GSTM1 null
subjects was 82 (43.4%), of which 46 (42.2%) exposed
and 36 (45.0%) controls. Only 21 (11.1%) subjects were
carriers of the GSTM1 null + CYP1A1 w1/m1 + m1/m1 com-
bined genotype, 13 (11.9%) exposed and 8 (10.0%) con-BMC Public Health 2007, 7:270 http://www.biomedcentral.com/1471-2458/7/270
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trols; 10 (5.3%) subjects presented the GSTM1  null +
CYP1A1 w2/m2 + m2/m2 combined genotype, 5 (4.6%)
exposed and 5 (6.3%) controls; 9 (4.8%) individuals were
carriers of the susceptible GSTM1 null + CYP1A1 w1/m1 +
m1/m1 +  CYP1A1  w2/m2 + m2/m2 genotype, 5 (4.6%)
exposed and 4 (5.0%) controls.
Influence of Exposure on the Biological End-Points
Statistically significant correlations were found between
the three different parameters measuring the extent of
DNA damage in leukocytes (i.e. tail length, tail intensity
and tail moment), thus data presentation will be limited
to tail intensity, also taking into account that relative tail
intensity (percentage of DNA migrated in the comet tail)
is considered to be the most useful parameter, as it bears
a linear relationship to strand-breaks frequency and is rel-
atively unaffected by threshold settings in the computer-
ized analysis system [42].
Group mean values (± SEM) of urinary 1OHP, individual
averaged percentage of DNA migrated in the comet tail
(i.e. tail intensity) and number of AST are listed in Table
3; the proportions of outlier subjects in exposed and con-
trol groups (i.e.  tail intensity) and the OR values are
showed in Table 4.
Urinary 1OHP was significantly higher in electrode work-
ers than in reference subjects, with 1OHP concentrations
about 18-fold higher in exposed workers than in controls
(p < 0.001). Smoking resulted in a statistically significant
increase of the 1OHP levels in controls (p < 0.001), but
not in the exposed group. Moreover, urinary 1OHP was
significantly lower (p = 0.046) in electrode workers older
than 40 respect to the youngest subjects. Urinary 1OHP
concentrations found in the present study correlate (r =
0.732) with the exposure to total PAH (data not shown).
Factory workers showed a statistical significant increase in
averaged DNA damage over that for controls (p = 0.002).
Smoking habit did not increase the extent of DNA dam-
age, both in the exposed and in the reference groups. Pri-
mary DNA damage was significantly higher (p = 0.036) in
electrode workers older than 40 respect to the youngest
subjects.
The group mean value of damaged cells (AST) is signifi-
cantly higher in the exposed than in control subjects (p <
0.001). Moreover, the number of 'outlier' subjects (sub-
jects showing a high number of AST) is significantly
higher in the exposed (38.5%) than in the control group
(19.5%), with an OR = 2.59 (CI95% 1.32–5.05). In the
group of exposed workers, the higher frequency of AST
and of outliers is mainly accounted by the subjects with an
age over 40 years, with an OR = 2.63 (CI95% 1.17–5.90).
Influence of Genotypes on the Biological End-Points
The influences of genetic polymorphisms on the concen-
tration of urinary 1OHP and the extent of primary DNA
damage are shown in Table 5. A statistically significant
influence of genetic polymorphisms was observed only
between exposed subjects with EPHX low or medium +
Table 1: Demographic characteristics of the study population 
grouped according to exposure status.
Exposed 
workers
Controls
Subjects 109 82
Demographic characteristicsa
Ageb 43.32 ± 0.56 42.99 ± 0.73
≤ 40 years 34 30
> 40 years 75 52
Occupational features
Duration of employmentb 14.34 ± 8.05 ---
≤ 10 years 36 ---
> 10 years 73 ---
Smoking habits
Non smokers 54 42
Smokers 55 40
Cigarettes/dayc 18.85 ± 9.14 14.92 ± 8.11
a All the subjects were males.
b Age and duration of employment are expressed in years and 
reported as the group mean ± standard deviation.
c The number of cigarettes smoked per day is reported as the mean ± 
standard deviation.
Table 2: Distribution of CYP1A1, EPHX, and GSTM1 genotypes in 
exposed and control subjects. Data are reported as the number 
of subjects (percentage between brackets).
Genotype Exposed 
workers
Controlsa
CYP1A1 (MspI)b w1/w1 79 (72.5) 67 (83.8)
w1/m1 + m1/m1 30 (27.5) 13 (16.3)
CYP1A1 (Ile/Val)c w2/w2 98 (89.9) 73 (91.3)
w2/m2 + m2/m2 11 (10.1) 7 (8.8)
EPHXd Low 59 (54.1) 35 (43.8)
Medium + High 50 (45.9) 45 (56.3)
GSTM1 Active 63 (57.8) 44 (55.0)
Null 46 (42.2) 36 (45.0)
a Two control subjects were not genotyped.
b w1 = common allele, m1 = variant allele.
c w2 = common allele; m2 = variant allele.
d mEH-deduced activity. The mEH activity deduction was based on the 
results of genotyping of polymorphisms in exons 3 and 4: subjects 
carrier of combination (exons 3 and 4) His113His + His139His, 
His113His + His139Arg, or Tyr113His + His139His, were considered 
as having "low" activity of mEH; subjects carrier of combination 
(exons 3 and 4) Tyr113Tyr + His139His, Tyr113His + His139Arg, or 
His113His + Arg139Arg, were considered as having "medium" activity 
of mEH; subjects carrier of combination (exons 3 and 4) Tyr113Tyr + 
His139Arg, Tyr113Tyr + Arg139Arg, or Tyr113His + Arg139Arg, 
were considered as having "high" activity of mEH [31].BMC Public Health 2007, 7:270 http://www.biomedcentral.com/1471-2458/7/270
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high deduced activity for 1OHP concentration in urine
samples.
Discussion
This study was designed to evaluate the occupational
exposure to PAH, as assessed by biological monitoring
techniques, in workers employed at a graphite electrode
manufacturing plant and in reference subjects with pre-
sumed lower exposure to PAH. Current exposure to PAH
was assessed by determining the urinary concentration of
1OHP (biomarker of internal dose), whereas biological
effect monitoring focused on the evaluation of primary
DNA damage extent as evaluated by the comet assay in
PBL (biomarker of biologically effective dose). Moreover,
in this study we analysed genetic polymorphisms in the
CYP1A1 (MspI and Ile/Val sites), EPHX (exons 3 and 4),
and GSTM1 genes to evaluate the impact of these meta-
bolic genotypes (biomarker of individual susceptibility)
on the levels of urinary 1OHP and the extent of primary
DNA damage.
Urinary 1OHP levels were significantly higher in exposed
workers than in matched controls. This finding is consist-
ent with the results of other studies aimed to determine
the effects of occupational exposure to PAH on urinary
1OHP concentrations [3,43-45]. The statistically signifi-
cant increase in urinary 1OHP levels observed in control
smokers as compared to control non smokers was not
confirmed in the group of exposed workers. This aspect
could be explained in terms of saturating dose, probably
due to the large work-related effects, at which no further
effect can be seen at higher doses.
In the comet assay, DNA strand breakage is quantified
from geometric (e.g. migration distance) and fluorescence
(e.g. per cent of fluorescence migrated in the tail) meas-
urements both by eye (i.e. comet score) or computerized
image analysis. In the presence of DNA damage, the dis-
tribution of tail parameters results strongly skewed to the
right and the two sides of the distribution have different
spreads. In this situation the mean is strongly influenced
by extreme observations and, as the resulting large stand-
ard deviation, appears to be rather uninformative. In this
situation, skewed not symmetrical distributions could be
defined more accurately by the median value (i.e. 50th
percentile) or the values corresponding to the 75th/95th
percentile [46]. This statistical approach in the comet
assay was adopted in several researches [47-49].
Table 3: Urinary concentration of 1-hydroxypyrene (1OHP) and extent of primary DNA damage in peripheral blood leukocytes in 
exposed workers and control subjects. Data reported as the group mean values (± SEM) of individual: urinary concentration of 1OHP 
(expressed as µg 1OHP/g creatinine), averaged tail intensity values (% of DNA migrated in the comet tail evaluated in 150 cells) and 
number of AST.
1OHP DNA damage
Averaged counts AST
Exposed
Total 2.64 ± 0.29* 5,28 ± 0,21* 11,75 ± 0,81*
≤ 40 years 2,96 ± 0,43* 4,63 ± 0,36 9,59 ± 1,35
> 40 years 2,49 ± 0,37* 5,58 ± 0,26* 12,73 ± 0,99*
Employment ≤ 10 years 2,23 ± 0,34 4,90 ± 0,29 10,14 ± 1,16
Employment > 10 years 2,84 ± 0,40 5,47 ± 0,28 12,55 ± 1,05
Non smokers 2.85 ± 0.47* 5.47 ± 0.30* 12,81 ± 1,14*
Smokers 2.43 ± 0.34* 5.11 ± 0.31 10,71 ± 1,14*
Controls
Total 0.15 ± 0.02 4,33 ± 0,22 7,50 ± 0,98
≤ 40 years 0.17 ± 0.03 4.34 ± 0.35 6,83 ± 1,51
> 40 years 0,14 ± 0,02 4,33 ± 0,28 7,88 ± 1,29
Non smokers 0.10 ± 0.02 4.23 ± 0.31 8,36 ± 1,60
Smokers 0.20 ± 0.02§ 4.44 ± 0.32 6,60 ± 1,12
* p < 0.05, exposed vs. controls; § p < 0.05, non-smokers vs. smokers. Non-parametric Mann-Whitney U-test (two-tailed).
Table 4: Proportions of outlier subjects in exposed and control 
groups. Data are referred to tail intensity (% of DNA migrated in 
the comet tail).
Exposed Controls OR (95% CI)
Total 42* 16 2.59 (1.32–5.05)
≤ 40 years 11 5 2.39 (0.72–7.93)
> 40 years 31* 11 2.63 (1.17–5.90)
Employment ≤ 10 years 15
Employment > 10 years 27
Non smokers 24* 9 2.93 (1.18–7.30)
Smokers 18 7 2.29 (0.85–6.18)
* p < 0.05, exposed vs. controls. Pearson-χ2 test.BMC Public Health 2007, 7:270 http://www.biomedcentral.com/1471-2458/7/270
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In epidemiological studies, enrolled subjects should be
characterized for a given aspect in a simple manner, pref-
erably with a single number. In this molecular epidemiol-
ogy approach we have chosen to describe the extent of
DNA damage only in terms of tail intensity, a parameter
describing the percentage of DNA migrated in the tail
which is relatively unaffected by threshold settings in the
computerized imaging [42].
As regard the extent of primary DNA damage, the comet
assay has been employed only in few studies aimed to
evaluate the PAH genotoxic effects in exposed workers
[45,50-55], with both positive and negative findings.
DNA single-strand breakage did not differ between 99
potroom workers at an aluminum reduction plant and 55
unexposed referents [50]. Occupational exposure to PAH
did not result in increased DNA strand breaks coke oven
workers as compared to unexposed subjects [55]. The
analysis of DNA damage did not show significant differ-
ences between 42 primary aluminium industry workers
and 16 local residents with no occupational exposure to
PAH [51]. No effect of occupational exposure was
observed in 50 coke oven workers as compared to 50 con-
trol workers not exposed to PAH in the extent of DNA
damage [45]. Exposure to PAH caused a significantly
higher single strand DNA breakage in lymphocytes and
granulocytes of 24 workers from automobile emission
inspection companies and 28 workers from a waste incin-
erating company as compared to 43 matched unexposed
subjects [54]. The extent of primary DNA damage evalu-
ated with the comet assay was found to be 3.13 times
higher for graphite-electrode-producing plant workers (n
= 29) when compared with controls (n = 32) [52]. Thus,
the findings of the present work are in line with the results
of the unique study considering graphite-electrode-pro-
ducing plant workers [52] and support the evidence that
occupational exposure to PAH during graphite electrode
manufacturing can result in primary DNA damage (strand
breakage as evaluated with the comet assay).
Smoking habit did not increase any of the DNA damage
parameters, either in the exposed than in the reference
group. The effect of smoking as a potential confounder in
occupational studies has been recently evaluated in a
meta-analysis study of the available, conflicting results
obtained with the comet assay [56]. The authors con-
cluded that an effect of smoking could not be formally
demonstrated when the evaluation of DNA damage was
based on image analysis.
Homozygous variant carriers of the CYP1A1  polymor-
phisms (MspI and Ile/Val) are extremely rare in Cauca-
sians [57]. The frequencies (all subjects) that we found
(2.65 and 0.53%, for MspI and Ile/Val, respectively) agree
with these observations. The EPHX  allele frequencies
found in this study are similar to those reported in non-
Table 5: Urinary concentration of 1-hydroxypyrene (1OHP) and extent of primary DNA damage in peripheral blood leukocytes in 
exposed workers and control subjects with respect to metabolic genotypes (CYP1A1, EPHX, and GSTM1). Data reported as the group 
mean values (± SEM) of individual: urinary concentration of 1OHP (expressed as µg 1OHP/g creatinine), averaged tail intensity values 
(% of DNA migrated in the comet tail evaluated in 150 cells) and number of AST.
1OHP DNA damage
Averaged counts AST
Exposed
CYP1A1 (MspI)b w1/w1 2.37 ± 0.29* 5.08 ± 2.45* 11.23 ± 0.92*
w1/m1 + m1/m1 3.33 ± 0.71* 5.81 ± 0.43 13.13 ± 1.65*
CYP1A1 (Ile/Val)c w2/w2 2.71 ± 0.31* 5.22 ± 0.22* 11.51 ± 0.84*
w2/m2 + m2/m2 1.96 ± 0.61* 5.85 ± 0.75 13.91 ± 2.95
EPHXd Low 2.17 ± 0.37*,§ 5.22 ± 0.30 12.63 ± 1.12*
Medium + High 3.19 ± 0.45* 5.00 ± 0.30* 10.72 ± 1.16*
GSTM1 Active 2.53 ± 0.38* 5.46 ± 0.29* 12.14 ± 1,09*
Null 2.79 ± 0.45* 5.05 ± 0.32 11.22 ± 1,21*
Controls
CYP1A1 (MspI)b w1/w1 0.14 ± 0.02 4.28 ± 0.25 7.24 ± 1.10
w1/m1 + m1/m1 0.21 ± 0.05 4.87 ± 0.53 6.54 ± 1.30
CYP1A1 (Ile/Val)c w2/w2 0.14 ± 0.02 4.38 ± 0.24 6.77 ± 0.91
w2/m2 + m2/m2 0.20 ± 0.07 4.25 ± 0.30 10.86 ± 5.08
EPHXd Low 0.13 ± 0.02 4.58 ± 0.33 7.34 ± 1.13
Medium + High 0.16 ± 0.02 4.21 ± 0.30 6.96 ± 1.43
GSTM1 Active 0.15 ± 0.02 4.49 ± 0.32 8.32 ± 1,48
Null 0.15 ± 0.03 4.23 ± 0.31 5.67 ± 1,02
a, b, c, d See notes in Table 2.
* p < 0.05, exposed vs. controls; § p < 0.05, EPHX Low vs. EPHX Medium + High. Non-parametric Mann-Whitney U-test.BMC Public Health 2007, 7:270 http://www.biomedcentral.com/1471-2458/7/270
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Hispanic whites [58]. The frequency of the GSTM1 null
genotype (43.4%) among the studied population (all sub-
jects) agrees with the frequencies reported in the literature
for the Caucasian population indicating that 40÷50% of
the considered subjects lack of GSTM1 activity [59,60].
Our results indicate that polymorphisms in EPHX exons 3
and 4 is associated to higher urinary concentrations of
1OHP, whereas the presence of variants in the CYP1A1
gene (i.e. MspI and Ile/Val mutations) as well as the pres-
ence of the GSTM1  null genotype showed to have no
effect on urinary 1OHP excretion. The increased urinary
excretion of 1OHP in subjects having a high EPHX activity
agrees with previously published results [61]. Whereas,
the absence of a relationship between urinary levels of
1OHP and the presence of the GSTM1 null genotype is
not unexpected, as 1OHP is mainly excreted as glucuro-
nide conjugate [62].
None of the genotypes analyzed (CYP1A1,  EPHX, and
GSTM1) had any significant influence on primary DNA
damage as evaluated by the comet assay. However, it was
reported that DNA damage by benzo(a)pyrene (i.e. benzo
[a]pyrene diolepoxide-DNA adducts) in PAH-exposed
coke oven workers is influenced by smoking habits and
GSTM1  polymorphisms [63,64]. Thus, it could be of
interest in the future, in workers exposed to high concen-
tration of PAH, to compare damage caused by
benzo(a)pyrene (such as BPDE-DNA adducts) and DNA
strand breakage (as evaluated with the comet assay) also
in relation to genetic polymorphisms.
No significant correlations were observed between urinary
levels of 1OHP and the extent of DNA strand breakage
(Spearman's correlation coefficients: r = 0.338, r = 0.157,
and  r  = 0.205, for tail length, tail intensity, and tail
moment, respectively) in this study. The absence of signif-
icant correlations could be explained in terms of different
persistence for the considered biomarkers. In fact, urinary
metabolites (i.e. 1OHP) mirror the exposure during the
last workshift and some days before [52], whereas the
alkaline comet assay measures temporary strand breaks
that happen before the DNA repair systems or cell turno-
ver occur [65].
Conclusion
The results of a cohort study among workers in a graphite
electrode production plant in Italy showed an excess of
mortality for cancer in these workers with a standardised
mortality ratio of 1.27 (CI95% 1.07–1.50) [66]. The main
strategy of primary cancer prevention is minimize expo-
sures to recognized genotoxic/carcinogenic risk factors.
The outcomes of the present study, together with the
results previously published by Marczynski et al. [52],
show that molecular epidemiology approaches (i.e. cross-
sectional studies of genotoxicity biomarkers) can play a
role in identifying common genetic risk factors, also
attempting to associate the effects with measured expo-
sure data. Moreover, categorization of subjects as normal
or outlier, as performed in this study, allowed the evalua-
tion of the association between exposure to genotoxins in
this occupational branch and DNA damage, highlighting
an increased genotoxic risk with a statistically significant
OR = 2.59 (CI95% 1.32–5.05).
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